awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36649162-B8DEC66F-9CE0-4B02-8116-5C0179F23F64
Q36649162-B8DEC66F-9CE0-4B02-8116-5C0179F23F64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36649162-B8DEC66F-9CE0-4B02-8116-5C0179F23F64
Bevacizumab as first-line therapy in advanced non-small-cell lung cancer: a brazilian center experience.
P2860
Q36649162-B8DEC66F-9CE0-4B02-8116-5C0179F23F64
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36649162-B8DEC66F-9CE0-4B02-8116-5C0179F23F64
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e5c0b489bd43b34db64f4604db2ebdb3728a710
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.